CN105213758A - 一种治疗慢性肺炎的中药组合物及其制备方法 - Google Patents
一种治疗慢性肺炎的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN105213758A CN105213758A CN201510798370.9A CN201510798370A CN105213758A CN 105213758 A CN105213758 A CN 105213758A CN 201510798370 A CN201510798370 A CN 201510798370A CN 105213758 A CN105213758 A CN 105213758A
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- chinese medicine
- medicine composition
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 37
- 230000001684 chronic effect Effects 0.000 title claims abstract description 26
- 239000000203 mixture Substances 0.000 title claims abstract description 24
- 206010035664 Pneumonia Diseases 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 239000009636 Huang Qi Substances 0.000 claims abstract description 14
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 14
- 241000208340 Araliaceae Species 0.000 claims abstract description 13
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 13
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 13
- 239000002671 adjuvant Substances 0.000 claims abstract description 13
- 235000008434 ginseng Nutrition 0.000 claims abstract description 13
- 210000000582 semen Anatomy 0.000 claims abstract description 13
- 235000015170 shellfish Nutrition 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 42
- 239000000706 filtrate Substances 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 12
- 238000010992 reflux Methods 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 239000008187 granular material Substances 0.000 claims description 7
- 239000000284 extract Substances 0.000 claims description 6
- 206010037660 Pyrexia Diseases 0.000 claims description 5
- 201000004792 malaria Diseases 0.000 claims description 5
- 208000008128 pulmonary tuberculosis Diseases 0.000 claims description 5
- 239000006187 pill Substances 0.000 claims description 4
- 206010006451 bronchitis Diseases 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 3
- 206010006458 Bronchitis chronic Diseases 0.000 claims description 2
- 208000031971 Yin Deficiency Diseases 0.000 claims description 2
- 239000011230 binding agent Substances 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 208000007451 chronic bronchitis Diseases 0.000 claims description 2
- 239000000945 filler Substances 0.000 claims description 2
- 239000000314 lubricant Substances 0.000 claims description 2
- 239000012567 medical material Substances 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 239000004094 surface-active agent Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 14
- 229940079593 drug Drugs 0.000 abstract description 8
- 208000024891 symptom Diseases 0.000 abstract description 6
- 239000000796 flavoring agent Substances 0.000 abstract description 3
- 235000019634 flavors Nutrition 0.000 abstract description 3
- 229940126678 chinese medicines Drugs 0.000 abstract description 2
- 238000005516 engineering process Methods 0.000 abstract description 2
- 210000004072 lung Anatomy 0.000 description 13
- 210000000952 spleen Anatomy 0.000 description 9
- 206010011224 Cough Diseases 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 208000004880 Polyuria Diseases 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 238000004806 packaging method and process Methods 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 230000002685 pulmonary effect Effects 0.000 description 3
- 201000006306 Cor pulmonale Diseases 0.000 description 2
- 206010011703 Cyanosis Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 206010014561 Emphysema Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000019693 Lung disease Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000004186 Pulmonary Heart Disease Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 206010046814 Uterine prolapse Diseases 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 210000001147 pulmonary artery Anatomy 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000000384 rearing effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 210000000115 thoracic cavity Anatomy 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 244000056139 Brassica cretica Species 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- 206010006322 Breath holding Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 206010018045 Gastroptosis Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 208000000857 Hepatic Insufficiency Diseases 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000000924 Right ventricular hypertrophy Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000000146 antalgic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 201000009267 bronchiectasis Diseases 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 238000000940 electromagnetic therapy Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 230000017525 heat dissipation Effects 0.000 description 1
- 208000000122 hyperventilation Diseases 0.000 description 1
- 230000000870 hyperventilation Effects 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000036593 pulmonary vascular resistance Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 208000030133 remittent fever Diseases 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗慢性肺炎的中药组合物及其制备方法,属于中药技术领域。所述一种治疗慢性肺炎的中药组合物,由药学上常用的辅料和以下重量份的原料制成:黄芪15-20份、鳖甲15-20份、茯苓10-20份、柴胡10-20份、芍药10-20份、桂枝10-15份、陈皮10-15份、白术10-15份、生地10-15份、贝母贝川10-15份、桔梗10-15份、苦杏仁10-15份、人参5-10份、甘草5-15份,再经过本发明公开的制作工艺制备而成。本发明由13味药组成,通过各药味之间又相互协同促进、平衡,能较好的缓解症状、治愈率高,治疗周期短且副作用小,具有实际应用价值和重大的现实意义。
Description
技术领域
本发明涉及中药技术领域,具体说是一种治疗慢性肺炎的中药组合物及其制备方法。
背景技术
肺炎,是指肺部的肺泡出现发炎的症状,病程超过3个月者为慢性肺炎。慢性肺炎容易周期性的复发和恶化,呈波浪型经过。由于病变的时期、年龄和个体的不同,症状多种多样。在静止期体温正常,无明显体征,几乎没有咳嗽,但在跑步和上楼时容易气喘。在恶化期常伴有肺功能不全,出现发绀和呼吸困难,并由于肺活量和呼吸储备减少及屏气时间缩短等,引起过度通气的外呼吸功能障碍。恶化后好转很缓慢,经常咳痰,甚至出现面部浮肿、发绀、胸廓变形和杵状指、趾。由于肺气肿、肺功能不全而引起肺循环阻力增高,肺动脉压力增高,右心负担加重,可在半年至两年内发生肺原性心脏病。还可能有肝功能障碍。白细胞增加,血沉中度增快。X线胸片显示在两肺中下野及肺门区肺纹理可呈蜂窝状,出现小泡性肺气肿,同时还可伴有实质性炎症病灶。两侧肺门阴影可见对称性增大。随病变的发展还可发生支气管扩张、右心室肥大及肺动脉段突出等肺原性心脏病的X线征象。
目前,治疗该病的药物多为抗病毒类的药物,反复感染时应用抗生素控制感染,肾上腺皮质激素也可起到抑制增生和促进病灶呼吸的作用,此外可用电磁疗法,超短波透热,按摩及芥末敷等物理疗法等辅助治疗。但是,以上治疗方法效果不明显,且容易复发,大量抗生素类的药物对人体也有一定的伤害。
中医认为,慢性肺炎属于肺热病,如重感冒、肺结核、支气管炎、慢性疟疾等可引起慢性咳嗽、弛张热、清耗热等症状,慢慢发展而成慢性肺炎。因此,治疗慢性肺炎应从清热、补气、活血等多方面着手,也为治疗该病提出了一种新的思路。
发明内容
本发明所要解决的技术问题是提供一种治疗慢性肺炎的中药组合物及其制备方法,由药学上常用的辅料和以下重量份的原料制成:黄芪15-20份、鳖甲15-20份、茯苓10-20份、柴胡10-20份、芍药10-20份、桂枝10-15份、陈皮10-15份、白术10-15份、生地10-15份、贝母贝川10-15份、桔梗10-15份、苦杏仁10-15份、人参5-10份、甘草5-15份。
作为优选的技术方案,所述的一种治疗慢性肺炎的中药组合物,由药学上常用的辅料和以下重量份的原料制成:黄芪17份、鳖甲17份、茯苓15份、柴胡15份、芍药15份、桂枝13份、陈皮13份、白术13份、生地13、贝母贝川13份、桔梗13份、苦杏仁13份、人参8份、甘草10份。
作为优选的技术方案,所述的一种治疗慢性肺炎的中药组合物片剂、胶囊剂、丸剂、颗粒剂。
本发明还提供了上述的制备方法,包括以下步骤:
(1)称取黄芪、鳖甲、茯苓、柴胡、芍药、桂枝、陈皮、白术、生地、贝母贝川、桔梗、苦杏仁、人参、甘草,备用;
(2)将称好的药材加入3-5倍重量的水煎煮2-3次,每次1-2小时,过滤;
(3)将步骤(2)中的滤液合并,在合并的滤液中加入90%的乙醇,并在蒸汽压力≤0.20Mpa、真空度≤-0.10Mpa的条件下浓缩;
(4)将步骤(3)中浓缩后的药液回流提取2次,然后再加入75%的乙醇回流提取2次,回收乙醇虑液;
(5)将回收的乙醇滤液低温干燥,粉碎,加入药学上可接受的辅料,混合,制成药剂。
在本发明中所述药学上常用的辅料选自填充剂、粘合剂、崩解剂、润滑剂、表面活性剂或矫味剂中的一种或几种。
本发明一种治疗慢性肺炎的中药组合物在制备治疗肺结核、慢性肺炎、慢性支气管炎、慢性疟疾、肺结核引起的骨蒸的药物中的用途。
本发明采用的原料药的药性、药理及作用如下:
黄芪:味甘性微温。归肺、脾、肝、肾经。补齐固表,托疮生肌。主治体虚自汗,久泻,脱肛,子宫脱垂,慢性肾炎,体虚浮肿,慢性溃疡,疮口久不愈合。生用黄芪,有益气固表、利水消肿、脱毒、生肌的功效。
鳖甲:味咸,性平。功效:滋阴潜阳,软坚散结。
茯苓:味甘、淡、性平,能渗湿利水;健脾和胃;宁心安神。主治小便不利;水肿胀满;痰饮咳逆;呕吐;脾虚食少;泄泻;心悸不安;失眠健忘;遗精白浊。
柴胡:解表退热;疏肝解郁,升举阳气。主外感发热;寒热往来;疟疾;肝郁胁痛乳胀;头痛头眩;月经不调;气虚下陷之脱肛;子宫脱垂;胃下垂。
芍药:具有镇痉、镇痛、通经作用。对的腹痛、胃痉挛、眩晕、痛风、利尿等病症有效。
桂枝:味辛、甘,性温;归心、肺、膀胱经。发汗解肌,温经通脉。治风寒表证,肩背肢节酸疼,胸痹痰饮,经闭症瘕。
白术:具有补气健脾、燥湿利水、止汗、安胎之功效。
生地:凉血滋阴。
贝母贝川:润肺散结,止嗽化痰。治虚劳咳嗽,吐痰咯血,心胸郁结,肺痿,肺痈,瘿瘤,廉疬,喉痹,乳痈。
桔梗:性平、味苦,辛,有小毒。归肺、胃经。具有祛痰、利咽、宣肺、排脓、利五脏、补气血的作用。
苦杏仁:具有抗炎镇痛、平喘等功效,有抗癌、降血糖、降血脂且美容等作用。
人参:性平、味甘、微苦,微温。归脾、肺经。功效:大补元气,复脉固脱,补脾益肺,生津止渴,安神益智。主治:劳伤虚损、食少、倦怠、反胃吐食、大便滑泄、虚咳喘促、自汗暴脱、惊悸、健忘、眩晕头痛、阳痿、尿频、消渴、妇女崩漏、小儿慢惊及久虚不复,一切气血津液不足之证。
甘草:性味甘平,归心、肺、脾、胃经。具补脾益气、润肺止咳、缓急止痛、缓和药性之功。
根据中医、中药辨证施治、君臣佐使的格局,对上述中药物进行科学配伍提出了有效的药物组合,作为本发明由13味药组成,可滋肾、解肝经和肺经瘀热,其中,生地、苦杏仁和贝母川母解肺热,贝母川母可止咳化痰;柴胡和芍药解肝热,而芍药又可活血;黄芪、茯苓、柴胡、桂枝、人参、甘草等固表补气、补脾、入肺经,桂枝和陈皮可理气,茯苓利尿。通过各药味之间又相互协同促进、平衡,能较好的缓解症状、治愈率高,治疗周期短且副作用小,具有实际应用价值和重大的现实意义。
具体实施方式
下面结合具体实施例对本发明做进一步地说明。
实施例1
称取黄芪150g、鳖甲150g、茯苓100g、柴胡100g、芍药100g、桂枝100g、陈皮100g、白术100g、生地100g、贝母贝川100g、桔梗100g、苦杏仁100g、人参50g、甘草50g,加入5倍重量的水煎煮2次,每次2小时,过滤;滤液合并,在合并的滤液中加入90%的乙醇,并在蒸汽压力≤0.20Mpa、真空度≤-0.10Mpa的条件下浓缩;将浓缩后的药液回流提取2次,然后再加入75%的乙醇回流提取2次,回收乙醇虑液。将回收的乙醇滤液低温干燥,粉碎,加入药学上可接受的辅料,混合均匀后制丸,低温干燥,整粒,包装,即得本发明的组合物,其为丸剂形式。
实施例2
称取黄芪170g、鳖甲170g、茯苓150g、柴胡150g、芍药150g、桂枝130g、陈皮130g、白术130g、生地130g、贝母贝川130g、桔梗130g、苦杏仁130g、人参80g、甘草100g,加入4倍重量的水煎煮2次,每次1.5小时,过滤;滤液合并,在合并的滤液中加入90%的乙醇,并在蒸汽压力≤0.20Mpa、真空度≤-0.10Mpa的条件下浓缩;将浓缩后的药液回流提取2次,然后再加入75%的乙醇回流提取2次,回收乙醇虑液。将回收的乙醇滤液低温干燥,粉碎,加入药学上可接受的辅料,混合均匀后制片,低温干燥,压片,包装,即得本发明的组合物,其为片剂形式。
实施例3
称取黄芪180g、鳖甲180g、茯苓160g、柴胡160g、芍药160g、桂枝140g、陈皮140g、白术140g、生地140g、贝母贝川140g、桔梗140g、苦杏仁140g、人参90g、甘草120g,加入3倍重量的水煎煮3次,每次1小时,过滤;滤液合并,在合并的滤液中加入90%的乙醇,并在蒸汽压力≤0.20Mpa、真空度≤-0.10Mpa的条件下浓缩;将浓缩后的药液回流提取2次,然后再加入75%的乙醇回流提取2次,回收乙醇虑液。将回收的乙醇滤液低温干燥,粉碎,加入药学上可接受的辅料,混合均匀后制粒,低温干燥,整粒,包装,即得本发明的组合物,其为胶囊剂形式。
实施例4
称取黄芪200g、鳖甲200g、茯苓200g、柴胡200g、芍药200g、桂枝150g、陈皮150g、白术150g、生地150g、贝母贝川150g、桔梗150g、苦杏仁150g、人参100g、甘草150g,加入5倍重量的水煎煮2次,每次2小时,过滤;滤液合并,在合并的滤液中加入90%的乙醇,并在蒸汽压力≤0.20Mpa、真空度≤-0.10Mpa的条件下浓缩;将浓缩后的药液回流提取2次,然后再加入75%的乙醇回流提取2次,回收乙醇虑液。将回收的乙醇滤液低温干燥,粉碎,加入药学上可接受的辅料,混合均匀后制粒,低温干燥,整粒,包装,即得本发明的组合物,其为颗粒剂形式。
药物药学和临床试验
1、急性毒性试验:
将实施例1-3所得药剂分别研磨成粉,溶于适量纯水中,配制成浓度为2.5g/ml的悬液;选取清洁级昆明种小鼠40只,雌雄各半,体重18~22g,随机分为两组,分别为试验组和对照组,每组20只,雌雄分笼饲养,饲养条件:温度20~24℃,相对湿度40%~60%,采用人工昼夜,早6点至晚6点光照,其余12小时黑暗,自由饮水,无进食;对试验组小鼠进行超剂量灌胃给药,给药浓度为45ml/kg,24h内灌胃三次,每次间隔6h,试验组的给药浓度为100g/kg,该剂量为相当于成人每日服用剂量(0.02g/kg)的5000倍,对照组按照同方法同剂量给予蒸馏水,连续观察7天;
观察结果:试验组小鼠给药第一天,较对照组小鼠活动减少,外观、排泄正常,第二天后外观、排泄等均正常;
结论:试验组小鼠的最大给药浓度为100g/kg(LD50>100g/kg),该剂量为相当于成人每日服用剂量(0.02g/kg)的5000倍,但小鼠无一死亡,行为正常,提示该中药制剂毒性极低,临床用药安全。
长期临床观察
发明人曾对本发明的药方多次改动,最终确定为本发明公开的配伍组合,且先后治疗了近300多例患者,经过多年的跟踪调查统计,用药初期有效率达98%,经过坚持治疗后,治愈率高达94%以上。由于患者本身的原因,有些患者没有坚持连续性的服药,至今仍未痊愈,但已经效果显著。通过近几年的观察,几乎没有毒副作用,患者没有出现病情复发或其他等症状。
本发明中用到的设备均为本领域的常用设备,在此不再赘述。
以上所述仅为本发明示意性的具体实施方式,并非用以限定本发明的范围。任何本领域的技术人员,在不脱离本发明的构思和原则的前提下所作出的等同变化与修改,均应属于本发明保护的范围。
Claims (6)
1.一种治疗慢性肺炎的中药组合物,其特征在于,由药学上常用的辅料和以下重量份的原料制成:黄芪15-20份、鳖甲15-20份、茯苓10-20份、柴胡10-20份、芍药10-20份、桂枝10-15份、陈皮10-15份、白术10-15份、生地10-15份、贝母贝川10-15份、桔梗10-15份、苦杏仁10-15份、人参5-10份、甘草5-15份。
2.一种治疗慢性肺炎的中药组合物,其特征在于,由药学上常用的辅料和以下重量份的原料制成:黄芪17份、鳖甲17份、茯苓15份、柴胡15份、芍药15份、桂枝13份、陈皮13份、白术13份、生地13、贝母贝川13份、桔梗13份、苦杏仁13份、人参8份、甘草10份。
3.根据权利要求1或2所述的一种治疗慢性肺炎的中药组合物,其特征在于,该组合物为片剂、胶囊剂、丸剂、颗粒剂。
4.如权利要求1或2所述的一种治疗慢性肺炎的中药组合物及其制备方法,的制备方法,其特征在于,包括以下步骤:
(1)称取黄芪、鳖甲、茯苓、柴胡、芍药、桂枝、白术、生地、贝母贝川、桔梗、苦杏仁、人参、甘草,备用;
(2)将称好的药材加入3-5倍重量的水煎煮2-3次,每次1-2小时,过滤;
(3)将步骤(2)中的滤液合并,在合并的滤液中加入90%的乙醇,并在蒸汽压力≤0.20Mpa、真空度≤-0.10Mpa的条件下浓缩;
(4)将步骤(3)中浓缩后的药液回流提取2次,然后再加入75%的乙醇回流提取2次,回收乙醇虑液;
(5)将回收的乙醇滤液低温干燥,粉碎,加入药学上可接受的辅料,混合,制成药剂。
5.根据权利要求1或2所述的一种治疗慢性肺炎的中药组合物,其特征在于,所述药学上常用的辅料为选自填充剂、粘合剂、崩解剂、润滑剂、表面活性剂或矫味剂中的一种或几种。
6.根据权利要求1-2所述的一种治疗慢性肺炎的中药组合物在制备治疗肺结核、慢性肺炎、慢性支气管炎、慢性疟疾、肺结核引起的骨蒸的药物中的用途。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510798370.9A CN105213758A (zh) | 2015-11-19 | 2015-11-19 | 一种治疗慢性肺炎的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510798370.9A CN105213758A (zh) | 2015-11-19 | 2015-11-19 | 一种治疗慢性肺炎的中药组合物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105213758A true CN105213758A (zh) | 2016-01-06 |
Family
ID=54983270
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510798370.9A Withdrawn CN105213758A (zh) | 2015-11-19 | 2015-11-19 | 一种治疗慢性肺炎的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105213758A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107174629A (zh) * | 2016-08-03 | 2017-09-19 | 李欣 | 慢性肺炎养肺缓咳中药剂 |
CN111467459A (zh) * | 2020-03-31 | 2020-07-31 | 西安市中医医院 | 一种用于新型冠状病毒肺炎恢复阶段的中药组合物、应用及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103520694A (zh) * | 2013-10-25 | 2014-01-22 | 梁轶聪 | 治疗慢性阻塞性肺病稳定期的中药组合物及其制备方法 |
-
2015
- 2015-11-19 CN CN201510798370.9A patent/CN105213758A/zh not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103520694A (zh) * | 2013-10-25 | 2014-01-22 | 梁轶聪 | 治疗慢性阻塞性肺病稳定期的中药组合物及其制备方法 |
Non-Patent Citations (1)
Title |
---|
刘五一等: "清热活血化癖治疗慢性肺炎21 例疗效分析", 《实用医学杂志》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107174629A (zh) * | 2016-08-03 | 2017-09-19 | 李欣 | 慢性肺炎养肺缓咳中药剂 |
CN111467459A (zh) * | 2020-03-31 | 2020-07-31 | 西安市中医医院 | 一种用于新型冠状病毒肺炎恢复阶段的中药组合物、应用及其制备方法 |
CN111467459B (zh) * | 2020-03-31 | 2021-07-23 | 西安市中医医院 | 一种用于新型冠状病毒肺炎恢复阶段的中药组合物、应用及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103432559B (zh) | 一种治疗血滞型月经减少及痛经的中药组合物及其制备方法和用途 | |
CN104740437A (zh) | 一种治疗便秘的中药组合物及其制备方法 | |
CN102671178A (zh) | 一种治疗肾病综合症及尿毒症的中药组合物配制方法及应用 | |
CN104645249B (zh) | 一种治疗冠心病心绞痛的药物 | |
CN102488784A (zh) | 一种治疗腰疼的中药组合物 | |
CN103251878B (zh) | 一种抗疲劳的中药组合物 | |
CN105213758A (zh) | 一种治疗慢性肺炎的中药组合物及其制备方法 | |
CN101675983A (zh) | 气虚症温补剂 | |
CN104623600A (zh) | 一种治疗末梢神经炎的中药及其制备方法 | |
CN104547736A (zh) | 一种治疗甲状腺肿的药物 | |
CN104274649A (zh) | 一种用于口腔溃疡的药物 | |
CN105106919B (zh) | 一种保健药酒及其制备方法和应用 | |
CN103285162A (zh) | 用于补肾壮阳的中药组合物及其制备方法 | |
CN102743455A (zh) | 一种治疗糖尿病的中成药 | |
CN100431584C (zh) | 一种健胸丰乳的中药制剂 | |
CN106728835B (zh) | 一种治疗糖尿病的中药 | |
CN104524535A (zh) | 一种治疗慢性肺源性心脏病的中药组合物及其制备方法 | |
CN103520476A (zh) | 一种健脾利湿祛痰止咳的中药制剂 | |
CN109078157A (zh) | 一种抗肿瘤药物及其制备方法 | |
CN103330861B (zh) | 一种治疗霍乱的药物及其制备方法 | |
CN101385844B (zh) | 一种治疗偏瘫的中药组合物及其制备方法 | |
CN105362596A (zh) | 一种治疗肺气肿的中药及其制备方法 | |
CN104740193A (zh) | 一种治疗颈肩肌肉劳损综合症的中药组合物及其制备方法 | |
CN104162112B (zh) | 一种药物组合物及其制备方法 | |
CN105106761A (zh) | 一种治疗脊髓损伤的中药及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20160106 |